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ABSTRACT
Heat shock proteins (HSPs) are molecular chaperones that bind to other proteins to 
shepherd them across membranes and direct them to specific locations within a cell. 
Several injurious stimuli can induce Hsp70 expression, including ischemia. This study 
aimed to investigate the pattern of expression of protein (immunohistochemistry) and 
gene (real-time PCR) Hsp70 in experimental focal cerebral ischemia in rats by occlusion of 
the middle cerebral artery for 1 hour and the role of neuroprotection with hypothermia (H) 
and ketoprofen (K). The infarct volume was measured using morphometric analysis defined 
by triphenyl tetrazolium chloride. It was observed increases in the protein (p=0.0001) and 
gene (p=0.0001) Hsp70 receptor in the ischemic areas that were reduced by H (protein 
and gene: p<0.05), K (protein: p<0.001), and H+K (protein: p<0.01 and gene: p<0.05). The 
Hsp70 increases in the ischemic area suggests that the Hsp70-mediated neuroexcitotoxicity 
plays an important role in cell death and that the neuroprotective effect of both, H and K 
are directly involved with the Hsp70.
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Expressão de HSP70 na isquemia cerebral e a ação neuroprotetora da hipotermia e 
do cetoprofeno
RESUMO
Proteínas de choque térmico (HSPs) são chaperones moleculares que se ligam a outras 
proteínas para atravessar as membranas e encaminhá-las para locais específicos dentro 
de uma célula. Vários estímulos nocivos podem induzir a expressão de Hsp70, incluindo 
isquemia. Este estudo teve como objetivo investigar o padrão de expressão protéica 
(imunohistoquímica) e gênica (PCR em tempo real) de Hsp70 na isquemia cerebral focal 
experimental em ratos pela oclusão da artéria cerebral média durante 1 hora e o papel da 
neuroproteção com hipotermia (H) e cetoprofeno (C). O volume de infarto foi calculado através 
da análise morfométrica definido por cloreto de trifenil tetrazólio. Foi observado aumento na 
expressão proteína (p=0,0001) e gênica (p=0,0001) de Hsp70 nas áreas isquêmicas que foram 
reduzidas pela H (proteína e gene: p<0,05), C (proteína: p<0,001) e H+K (proteína: p<0,01 e 
gene: p<0,05). O aumento de Hsp70 na área isquêmica sugere que a neuroexcitotoxicidade 
mediada pela Hsp70 desempenha um papel importante na morte celular e que o 
efeito neuroprotetor tanto da H quanto do C está diretamente envolvido com a Hsp70. 
Palavras-chave: expressão de Hsp70, isquemia cerebral, neuroproteção, hipotermia, 
cetoprofeno.
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Focal cerebral ischemia produces chang-
es in gene transcription and translation 
that are related to the extent of blood flow 
reduction. While total protein synthesis 
is generally reduced with ischemia, some 
genes, including the c-fos immediate ear-
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ly gene and the 70 kD heat shock stress gene Hsp70, are 
induced with ischemia1-3.
The heat shock protein (HSP) family is induced in the 
brain by several insults including excitotoxin exposure, 
trauma, elevated body temperature and cerebral isch-
emia4-7. The Hsp70 expression is elevated mainly in the 
area of ischemic penumbra8-10 and delection of the Hsp70 
gene exacerbate apoptosis after focal cerebral ischemia in 
mice11. Olsson et al.6 suggested that the increased expres-
sion of the Hsp70 is an indicator of cellular stress. Recent 
work has shown that HSP proteins modulate inflammato-
ry response either by potentiating12 or inhibiting them13,14 
and suggest that Hsp70 brain protection against ischemia 
is done through an anti-inflammatory mechanism. 
Several pharmacological procedures have been used 
in an attempt to reduce the area involved in the ischemic 
process. Among them, hypothermia15,16 and anti-inflam-
matory drugs17-19 and hypothermia in combination with 
anti-inflammatory drugs18, has proved to be effective in 
providing protection after cerebral ischemia. Anti-inflam-
matory agents are used to attenuate the inflammatory re-
sponse triggered by the ischemic phenomenon18, with em-
phasis on ketoprofen17,19, a non steroid agent with a very 
potent analgesic and anti-inflammatory action, acting as a 
possible antagonist of the N-methyl-d-aspartate receptors 
(NMDARs)20. Its neuroprotective effect was attributed by 
Asanuma et al.17 to decrease the antagonism of acetylcho-
line receptors caused by transient ischemia in gerbils. Ex-
perimental studies have also demonstrated the protec-
tive action of ketoprofen against ischemia in neurons of 
the retina and brain tissues in transient focal ischemia21.
This study aimed to investigate the pattern of expres-
sion of protein and gene Hsp70, in an experimental mod-
el of transient focal cerebral ischemia without reperfusion 
and the possible neuroprotective effect of hypothermia 
and ketoprofen.
METHOD
One hundred and twenty adult male rats (Rattus nor-
vegicus) weighing 280-310 g were used and the animals 
were randomly divided into 3 experimental groups: con-
trol (C), 20 animals sacrificed without being submitted to 
the surgical procedure; sham (S), 20 control animals sub-
mitted to complete simulation of the surgical procedure 
but without obstruction of the middle cerebral artery 
(MCA) and then sacrificed, and ischemic (I), 80 animals 
submitted to focal ischemia by occlusion of the MCA for 
1 hour and then sacrificed. This group was subdivided 
into 4 subgroups of 20 animals each: ischemic subgroup 
(Sg I), ischemic subgroup submitted to hypothermia (Sg 
IH), ischemic subgroup treated with ketoprofen (Sg IK), 
and ischemic subgroup submitted to hypothermia and 
treated with ketoprofen (Sg IHK). Ten animals from each 
experimental group, for a total of 60 animals, were used 
for the delimitation of the ischemic area using a morpho-
metric method for controlling the efficacy and the exten-
sion of the ischemia. The experiments were carried out 
according to the Ethical Principles for Experimental An-
imals (COBAO) and the study was approved by the Ani-
mal Experimentation Committee (CETEA) of the Facul-
ty of Medicine of Ribeirão Preto, University of São Paulo 
(Protocol nº 0347/2005).
Induction of cerebral ischemia
All animals were partially anesthetized by halothane 
inhalation and intubated with an orotracheal cannula. At 
two times during the ischemic period, arterial blood sam-
ples were collected for the determination of glycemia, pa-
CO2, paO2 and pH. The animals in the Sg IH subgroup 
were submitted to moderate intra-ischemic hypotherm-
ia (32-34oC) by anesthesia itself and by air conditioning 
the room, starting 15 minutes before the surgical proce-
dure to induce ischemia. The animals in the Sg IK sub-
group received an intravenous injection of ketoprofen at 
the dose of 10 mg/kg body weight 15 minutes before the 
induction of ischemia, and the animals in the Sg IHK sub-
group were submitted to intra-ischemic hypothermia and 
similarly injected with ketoprofen. MCA occlusion was 
carried out through the external carotid artery which was 
ligated cranially and sectioned for the retrograde intro-
duction of a 2.5 cm long obstructive 4-0 mononylon su-
ture with one end thickened with silicone over an exten-
sion of 5 mm22. The suture was introduced until to reach 
the common carotid artery and then cranially progressed 
through the internal carotid artery until to reach and to 
obstruct the MCA.
Morphometric analysis of infarct volume
Infarct volumes were measured by morphometric 
analysis of infarct areas that were defined by 2,3,5-triph-
enyl tetrazolium (TTC). The brains of the animals were 
removed and cut into coronal sections using a rat brain 
matrice and were placed in a 2% solution of the dye TTC, 
developed at 37oC for 30 minutes, and then stored in 10% 
buffered formalin solution. Cross-sectional area of the 
TTC-stained region for each brain slice was determined 
using an image analyzer (Axion vision 4.6 - Carl Zeiss). Af-
ter integration of these stained areas, the indirect method 
of Swanson et al.23 was used to determine infarct volume 
(subtraction of residual left hemisphere cortical volume 
from the cortical volume of the intact right hemisphere). 
Analysis of protein expression 
by immunohistochemistry
The samples were embedded in paraffin and coronal 
sections (3 μm) of the brain were incubated with 3% H2O2 
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and Pierce solution to block endogenous peroxidase and 
biotin, respectively. Sections were subsequently incubat-
ed with primary antibody against Hsp70 (1:200 dilution 
- CHEM - AB9864 - Chemicon®) and with biotin-con-
jugated secondary anti-rabbit antibody (1:1000; Vector 
Laboratories Inc., Burlingame, CA) and streptavidin-con-
jugated peroxidase (Vecstatin Abc kit, Vector Laborato-
ries Inc.). Color was developed by the addition of DAB 
(Sigma Chemical, St. Louis, MO). To evaluate the back-
ground reaction, procedures were also performed in sec-
tions incubated only with the secondary antibodies (indi-
rect technique) or in the absence antibodies (direct tech-
nique). For the analysis of protein expression of Hsp70 a 
field in an increase of 400× in the area where there was 
greater concentration of positive cells or marked (areas 
of “hot spots”) was selected in each layer of immunohis-
tochemical reaction. The number with positive staining 
for Hsp70 was measured by using a camera (Axio Cam, 
Zeiss, Germany) and the software Axiovision 4.6 (Zeiss, 
Germany).
The method used for counting the cells positive to 
antibody study was to quantify “in crosses” of cytoplas-
mic immunoreactivity of cells of nervous tissue. The fields 
chosen in the slides were evaluated as the percentage of 
cells marked and graded from 0 (zero): no mark, up to 
25%: 1 + (low expression), 25% to 50%: 2 ++ (intermedi-
ate expression); 50% to 75%: 3 +++ (high expression) and 
over 75% of cells marked: 4 ++++ (high expression).
RNA extraction and cDNA synthesis
After removal of the brain, the cortex of the left ce-
rebral hemisphere was isolated and a sample measuring 
7 mm in diameter, was obtained by biopsy from the cen-
tral ischemic region, corresponding to the irrigation zone 
of the MCA. The samples were placed in cryotubes and 
stored in liquid nitrogen at - 196oC until the time for RNA 
extraction. For this procedure, 250 μl PBS + 750 μl TRI-
ZOL were added to the brain tissue samples which were 
then lysed in a Polytron homogenizer for about 3 minutes. 
Next, total RNA was extracted by the TRIZOL method 
(Invitrogen, Carlsbad, CA, USA) according to manufac-
turer instructions. Complementary DNA (cDNA) was 
constructed by reverse transcription using the enzyme 
Superscript II and the DNA obtained was amplified by 
real-time quantitative PCR (RQ-PCR).
Analysis of gene expression patterns by RQ-pCR
For the quantitative analysis of the gene under study, 
Hsp70 (Rn 01525984), we used the commercially avail-
able system TaqMan Assay-on-demand, which consists of 
oligonucleotides and probes (Applied Biosystems, Foster 
City, CA, USA). Reverse transcription was performed us-
ing 4 µg total RNA for each sample in 40 µL of the total 
reaction mixture, with the addition of oligo (dT)20 (Cat. 
No. 18418-020, Invitrogen) and Superscript II reverse 
transcriptase (Cat. No. 18064-022, Invitrogen), accord-
ing to manufacturer instructions. The cDNA obtained 
was diluted 1:10 and 2.5 µL was used for each 15 µL of 
the RQ-PCR mixture using the TaqMan Master Mix (Ap-
plied Biosystems).
All reactions were carried out in duplicate and ana-
lyzed with the 7500 Sequence Detection System appara-
tus (Applied Biosystems). Data were analyzed using the 
ABI-7500 SDS software. The maximum standard devi-
ation between duplicates was 10%. The total RNA ab-
sorbed was normalized on the basis of the Ct value for the 
GAPDH gene (Rn_99999916). The variation of expression 
among samples was calculated by the 2–∆∆Ct method, with 
the mean delta Ct value for a group of 20 samples from 
control rats being used as a calibrator.
statistical analysis
The expression of the gene and protein under study 
showed normal distribution in the various groups. Data 
concerning the mean gene and protein expression in the 
various groups were analyzed statistically by one-way 
ANOVA followed by the Bonferroni post-test using the 
GraphPad Prism software, version 4.00 for Windows, 
(GraphPad Software, San Diego, CA, USA). The level of 
significance was set at p<0.05 for two-tailed tests.
RESULTS
Rats subjected to a 60 minutes period by occlusion of 
the MCA showed after morphometric analysis that the 
infarct area corresponding to the territory of irrigation 
of the MCA was clearly observed in the animals of the 
ischemic group. 
The analysis of the percentage of the volume of isch-
emic area in relation to the normal hemisphere among 
the animals of the ischemic group (SgIH, SgIK and SgI-
HK) revealed a smaller area of infarction in relation to an-
imals of the ischemic subgroup (SgI) (p<0.0001, one-way 
ANOVA, p=0001, Bonferroni post-test, and similar areas 
to that observed in animals of the control group. 
The analysis of protein expression of Hsp70 by immu-
nohistochemistry (Fig 1) showed that it was intermediate 
(++) for all animals in subgroups SgI, SgIH and SgIHK, 
and that average percentage of positive cells were 40.96%; 
36.73% and 36.20%, respectively. The expression was also 
intermediate (++) for all animals of the subgroup SgIK, 
with low intensity (+) only in animal 2 and with the aver-
age percentage of positive cells of 28.61%.
Fig 2 shows mean and standard deviation of the per-
centage of positive cells to Hsp70 antibody in the isch-
emic group. There was a statistically significant difference 
(p=0.0001 one-way ANOVA) between the subgroups 
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SgIxSgIH (p<0.05), SgIxSgIK (p<0.001), SgIxSgIHK 
(p<0.01), Bonferroni post test.
Fig 3 illustrates the mean expression of the Hsp70 
gene in the experimental groups. The expression in the 
animals of the ischemic group was higher when com-
pared with control and sham (p=0.0001, one-way ANO-
VA, p<0.05, Bonferroni post-test), and it was lower in the 
animals of the subgroups SgIH and SgIHK compared to 
control, sham and ischemic (SgI) animals (p=0.0001, one-
way ANOVA, p<0.05, Bonferroni post-test). 
DISCUSSION
Cerebral ischemia is one of the devastating neuro-
pathological disorders known to humans. Though sever-
al putative molecules have been investigated for pharma-
cological intervention for preventing or reducing cerebral 
ischemia, no successful therapy has been achieved24.
The model of ischemia induction by occlusion of the 
MCA with an obstructive suture has been used by sever-
al investigators and has been shown to produce constant 
and reproducible focal injuries19,22. In our study, morpho-
logical measure of the infarct volume was randomly per-
formed in 10 animals of each experimental group for con-
trolling the occurrence of ischemia. All animals submit-
ted to ischemia showed some evidence of infarct in the 
ischemic hemisphere. The sham group, consisting of ani-
mals subjected to complete simulation of the surgical pro-
cedure, but without obstruction of the MCA, was used 
in order to demonstrate that the surgical procedure that 
these animals are subjected to the access to the MCA 
does not affect the results obtained and therefore differ-
ent from control animals, which does not undergo any 
procedure before the sacrifice.
Modulation of inflammatory response by Hsp70 is 
controversial: some suggest potentialization by this pro-
tein12 and others inhibition13,14. Zheng et al.14, suggest that 
overexpression of Hsp70 not only protect brain against 
ischemia but also appear to do via an anti-inflammato-
ry mechanism. 
As several pathways leading to cell death are activated 
after an ischemic insult, effective neuroprotection might re-
quire a combination of drugs that target distinct pathways 
during the evolution of ischemic injury. This has led to a 
number of papers studying combinations of pharmacolog-
ical agents25-27 and multiple mechanisms for hypothermia-
induced neuroprotection have already been identified28-30.
Using a global model of cerebral ischemia in mice, 
Olsson et al.6 noted a change in Hsp70 expression in the 
sg I: ischemic subgroup; sg IK: ischemic+ketoprofen subgroup; 
sg Ih: ischemic+hypothermia subgroup; sg IhK: ischemic+hypo-
thermia+ ketoprofen subgroup.
Fig 2. Mean and standard deviation of the percentage of positive 
cells to Hsp70antibody in the ischemic group.
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Fig 3. Gene expression of the Hsp70 gene in the groups studied. 
Data are reported as means ±SD. The deviation bars indicate a 
95% confidence interval.
Fig 1. Photomicrography of the expression of Hsp70 antibody in 
the SgIHK subgroup. Positive cells (*) and negative cells (**) in the 
nervous tissue to the antibody (400×).
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CA1-CA3 regions of the hippocampus. When coupled 
with hypothermia (33°C) there was a decrease in the ex-
pression of Hsp70 and consequent decrease in cellular 
damage. The authors suggest that increased expression 
of Hsp70 in cerebral ischemia is an indicator of cellular 
stress. Our results corroborated the data of literature that 
decrease of Hsp70 lead to an neuroprotector effect and 
this effect also was observed when this protein with hy-
pothermia and ketoprofen alone as ketoprofen plus hy-
pothermia. More studies with this drug are necessary for 
better understanding participation of the Hsp70 in the in-
flammatory response and especially its actions as anti-in-
flammatory agent in ischemic brain.
In conclusion, the increased expression in the HSP70 
after experimental ischemia suggests its involvement with 
cerebral ischemia. The neuroprotective agents associat-
ed with ischemia evaluated in this study (hypothermia, 
ketoprofen and hypothermia+ketoprofen) proved to be 
effective. This was suggested by the reduction of both 
gene and protein expression of HSP70. The association 
between hypothermia+ketoprofen do not proved to be 
more effective then the isolated action of these two neu-
roprotective agents.
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